Cited by 925Parkinson's Disease Mechanisms and TreatmentsAlzheimer's disease research and treatmentsNuclear Receptors and Signaling

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats

Open access

Holmqvist, Staffan, Chutna, Oldriska, Bousset, Luc, Aldrin-Kirk, Patrick, Li, Wen, Björklund, Tomas, Wang, Zhan-You, Roybon, Laurent, Melki, Ronald, Li, Jia-Yi·2014·Acta Neuropathologica

DOI 10.1007/s00401-014-1343-6

Open this paper in CoChat — free account

Abstract

The cellular hallmarks of Parkinson's disease (PD) are the loss of nigral dopaminergic neurons and the formation of α-synuclein-enriched Lewy bodies and Lewy neurites in the remaining neurons. Based on the topographic distribution of Lewy bodies established after autopsy of brains from PD patients, Braak and coworkers hypothesized that Lewy pathology primes in the enteric nervous system and spreads to the brain, suggesting an active retrograde transport of α-synuclein (the key protein component in Lewy bodies), via the vagal nerve. This hypothesis, however, has not been tested experimentally thus far. Here, we use a human PD brain lysate containing different forms of α-synuclein (monomeric, oligomeric and fibrillar), and recombinant α-synuclein in an in vivo animal model to test this hypothesis. We demonstrate that α-synuclein present in the human PD brain lysate and distinct recombinant α-synuclein forms are transported via the vagal nerve and reach the dorsal motor nucleus of the vagus in the brainstem in a time-dependent manner after injection into the intestinal wall. Using live cell imaging in a differentiated neuroblastoma cell line, we determine that both slow and fast components of axonal transport are involved in the transport of aggregated α-synuclein. In conclusion, we here provide the first experimental evidence that different α-synuclein forms can propagate from the gut to the brain, and that microtubule-associated transport is involved in the translocation of aggregated α-synuclein in neurons.

Integrity signals

Registry

Crossref · 10.1007/s00401-014-1343-6

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Microtubules as a target for anticancer drugs
Jordan, M. A., & Wilson, L. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1317 · Cited by 4,000
Mobility measurement by analysis of fluorescence photobleaching recovery kinetics
Axelrod, D., Koppel, D. E., Schlessinger, J., Elson, E. L., & Webb, W. W. (1976) · Biophysical Journal · doi:10.1016/s0006-3495(76)85755-4 · Cited by 2,717
Stages in the development of Parkinson’s disease-related pathology
Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., & Del Tredici, K. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0956-9 · Cited by 2,689
Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · Science · doi:10.1126/science.1227157 · Cited by 2,563
Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation
Li, J.-Y., Englund, E., Holton, J. L., Soulet, D., Hagell, P., Lees, A. J., Lashley, T., Quinn, N. P., Rehncrona, S., Björklund, A., et al. (2008) · Nature Medicine · doi:10.1038/nm1746 · Cited by 1,845
Self-citation
Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease
Kordower, J. H., Chu, Y., Hauser, R. A., Freeman, T. B., & Olanow, C. W. (2008) · Nature Medicine · doi:10.1038/nm1747 · Cited by 1,722
Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen
Braak, H., R�b, U., Gai, W. P., & Del Tredici, K. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-002-0808-2 · Cited by 1,683
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein
Desplats, P., Lee, H.-J., Bae, E.-J., Patrick, C., Rockenstein, E., Crews, L., Spencer, B., Masliah, E., & Lee, S.-J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903691106 · Cited by 1,485
In vivo demonstration that α-synuclein oligomers are toxic
Winner, B., Jappelli, R., Maji, S. K., Desplats, P. A., Boyer, L., Aigner, S., Hetzer, C., Loher, T., Vilar, M., Campioni, S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100976108 · Cited by 1,463

Flagged first, then by citations

Show all 51 references

Sorted by citations

Items 201–300 of 925

Gut-induced alpha-Synuclein and Tau propagation initiate Parkinson’s and Alzheimer’s disease co-pathology and behavior impairments
Xiang, J., Tang, J., Kang, F., Ye, J., Cui, Y., Zhang, Z., Wang, J., Wu, S., & Ye, K. (2024) · Neuron · doi:10.1016/j.neuron.2024.08.003 · Cited by 83
Gut microbiota dysbiosis in Parkinson disease: A systematic review and pooled analysis
Bardenhorst, S. K., Cereda, E., Severgnini, M., Barichella, M., Pezzoli, G., Keshavarzian, A., Desideri, A., Pietrucci, D., Aho, V. T. E., Scheperjans, F., et al. (2023) · European Journal of Neurology · doi:10.1111/ene.15671 · Cited by 87
The gut-brain axis and Parkinson disease: Clinical and pathogenetic relevance
Menozzi, E., Macnaughtan, J., & Schapira, A. H. V. (2021) · Annals of Medicine · doi:10.1080/07853890.2021.1890330 · Cited by 81
Propagation of pathologic α-synuclein from kidney to brain may contribute to Parkinson’s disease
Yuan, X., Nie, S., Yang, Y., Liu, C., Xia, D., Meng, L., Xia, Y., Su, H., Zhang, C., Bu, L., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-024-01866-2 · Cited by 86
Microbiome, Parkinson’s Disease and Molecular Mimicry
Miraglia, F., & Colla, E. (2019) · Cells · doi:10.3390/cells8030222 · Cited by 84
Enteric glia in homeostasis and disease: From fundamental biology to human pathology
Rosenberg, H. J., & Rao, M. (2021) · iScience · doi:10.1016/j.isci.2021.102863 · Cited by 83
Sleep, circadian rhythm and gut microbiota: alterations in Alzheimer’s disease and their potential links in the pathogenesis
Li, Y., Shao, L., Mou, Y., Zhang, Y., & Ping, Y. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1957407 · Cited by 84
How microbiota shape microglial phenotypes and epigenetics
Erny, D., & Prinz, M. (2020) · Glia · doi:10.1002/glia.23822 · Cited by 80
Intranasal administration of α-synuclein preformed fibrils triggers microglial iron deposition in the substantia nigra of Macaca fascicularis
Guo, J., Yue, F., Song, D., Bousset, L., Liang, X., Tang, J., Yuan, L., Li, W., Melki, R., Tang, Y. C., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-020-03369-x · Cited by 74
Self-citation
Mechanisms of alpha-synuclein toxicity: An update and outlook
Brás, I. C., Xylaki, M., & Outeiro, T. F. (2019) · Progress in brain research · doi:10.1016/bs.pbr.2019.10.005 · Cited by 78
Animal models of brain-first and body-first Parkinson's disease
Berge, N. V. D., & Ulusoy, A. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105599 · Cited by 80
Distribution of α-synuclein in the spinal cord and dorsal root ganglia in an autopsy cohort of elderly persons
Sumikura, H., Takao, M., Hatsuta, H., Ito, S., Nakano, Y., Uchino, A., Nogami, A., Saito, Y., Mochizuki, H., & Murayama, S. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0236-9 · Cited by 74
Appendectomy and risk of Parkinson's disease: A nationwide cohort study with more than 10 years of follow‐up
Svensson, E., Horváth–Puhó, E., Stokholm, M. G., Sørensen, H. T., Henderson, V. W., & Borghammer, P. (2016) · Movement Disorders · doi:10.1002/mds.26761 · Cited by 75
Gut microenvironmental changes as a potential trigger in Parkinson’s disease through the gut–brain axis
Chen, S., & Lin, C. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00839-6 · Cited by 85
Microbiota–gut–brain axis in health and neurological disease: Interactions between gut microbiota and the nervous system
He, Y., Wang, K., Su, N., Yuan, C., Zhang, N., Hu, X., Fu, Y., & Zhao, F. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70099 · Cited by 83
How strong is the evidence that Parkinson's disease is a prion disorder?
Brundin, P., Ma, J., & Kordower, J. H. (2016) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000349 · Cited by 76
α-Synuclein pre-formed fibrils impair tight junction protein expression without affecting cerebral endothelial cell function
Kuan, W., Bennett, N. K., He, X., Skepper, J. N., Martynyuk, N., Wijeyekoon, R., Moghe, P. V., Williams‐Gray, C. H., & Barker, R. A. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.09.003 · Cited by 73
Neuroprotective effects of an engineered commensal bacterium in the 1‐methyl‐4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine Parkinson disease mouse model via producing glucagon‐like peptide‐1
Fang, X., Tian, P., Zhao, X., Jiang, C., & Chen, T. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14694 · Cited by 72
Glucocerebrosidase-associated Parkinson disease: Pathogenic mechanisms and potential drug treatments
Gegg, M. E., Menozzi, E., & Schapira, A. H. V. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105663 · Cited by 77
C/EBPβ/AEP is age-dependently activated in Parkinson’s disease and mediates α-synuclein in the gut and brain
Wang, H., Chen, G., Ahn, E. H., Xia, Y., Kang, S. S., Liu, X., Liu, C., Han, M.-H., Chen, S., & Ye, K. (2023) · npj Parkinson's Disease · doi:10.1038/s41531-022-00430-8 · Cited by 71
NLRP3 Inflammasomes in Parkinson’s disease and their Regulation by Parkin
Yan, Y., Fang, Y., Zheng, R., Pu, J., & Zhang, B. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.08.004 · Cited by 72
Roles of α‑synuclein in gastrointestinal microbiome dysbiosis‑related Parkinson's disease progression (Review)
Lei, Q., Wu, T., Wu, J., Hu, X., Guan, Y., Wang, Y., Yan, J., & Shi, G. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12374 · Cited by 74
New avenues for Parkinson's disease therapeutics: disease-modifying strategies based on the gut microbiota
Lorente-Picón, M., & Laguna, A. (2021) · Biomolecules · doi:10.3390/biom11030433 · Cited by 69
Organotypic slice culture model demonstrates inter-neuronal spreading of alpha-synuclein aggregates
Elfarrash, S., Jensen, N. M., Ferreira, N., Betzer, C., Thevathasan, J. V., Diekmann, R., Adel, M., Omar, N. M., Boraie, M. Z., Gad, S., et al. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0865-5 · Cited by 70
Bacterial Extracellular Vesicles and the Gut‐Microbiota Brain Axis: Emerging Roles in Communication and Potential as Therapeutics
Pirolli, N. H., Bentley, W. E., & Jay, S. M. (2021) · Advanced Biology · doi:10.1002/adbi.202000540 · Cited by 71
Iron as the concert master in the pathogenic orchestra playing in sporadic Parkinson’s disease
Riederer, P. F., Monoranu, C., Strobel, S., Iordache, T., & Sian‐Hülsmann, J. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-021-02414-z · Cited by 69
Prion and Prion-Like Protein Strains: Deciphering the Molecular Basis of Heterogeneity in Neurodegeneration
Scialò, C., Cecco, E. D., Manganotti, P., & Legname, G. (2019) · Viruses · doi:10.3390/v11030261 · Cited by 69
Insights from late-onset familial parkinsonism on the pathogenesis of idiopathic Parkinson's disease
Volta, M., Milnerwood, A. J., & Farrer, M. J. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00186-6 · Cited by 69
Exocytosis and Spreading of Normal and Aberrant α‐Synuclein
Emmanouilidou, E., & Vekrellis, K. (2016) · Brain Pathology · doi:10.1111/bpa.12373 · Cited by 71
Assessments of plasma ghrelin levels in the early stages of Parkinson's disease
Song, N., Wang, W., Jia, F., Du, X., Xie, A., He, Q., Shen, X., Zhang, J., Rogers, J. T., Xie, J., et al. (2017) · Movement Disorders · doi:10.1002/mds.27095 · Cited by 67
Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy
Schaser, A. J., Stackhouse, T. L., Weston, L. J., Kerstein, P. C., Osterberg, V. R., López, C. S., Dickson, D. W., Luk, K. C., Meshul, C. K., Woltjer, R. L., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01026-0 · Cited by 63
A53T-α-synuclein overexpression in murine locus coeruleus induces Parkinson’s disease-like pathology in neurons and glia
Henrich, M. T., Geibl, F. F., Lee, B., Chiu, W., Koprich, J. B., Brotchie, J. M., Timmermann, L., Decher, N., Matschke, L. A., & Oertel, W. H. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0541-1 · Cited by 70
New hope for Parkinson’s disease treatment: Targeting gut microbiota
Fan, H., Sheng, S., & Zhang, F. (2022) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13916 · Cited by 66
Review: Spreading the word: precise animal models and validated methods are vital when evaluating prion‐like behaviour of alpha‐synuclein
Rey, N. L., George, S., & Brundin, P. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12299 · Cited by 67
LGALS3 (galectin 3) mediates an unconventional secretion of SNCA/α-synuclein in response to lysosomal membrane damage by the autophagic-lysosomal pathway in human midbrain dopamine neurons
Burbidge, K. J., Rademacher, D. J., Mattick, J., Zack, S. R., Grillini, A., Bousset, L., Kwon, O., Kubicki, K., Simon, A., Melki, R., et al. (2021) · Autophagy · doi:10.1080/15548627.2021.1967615 · Cited by 64
Self-citation
Stress and the gut-brain axis: an inflammatory perspective
Morys, J., Małecki, A., & Nowacka-Chmielewska, M. M. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1415567 · Cited by 81
Alzheimer's disease and symbiotic microbiota: an evolutionary medicine perspective
Fox, M. M., Knorr, D. A., & Haptonstall, K. P. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14129 · Cited by 67
Neurodegeneration and neuroinflammation are linked, but independent of alpha‐synuclein inclusions, in a seeding/spreading mouse model of Parkinson's disease
Garcia, P., Jürgens‐Wemheuer, W., Uriarte Huarte, O., Michelucci, A., Masuch, A., Brioschi, S., Weihofen, A., Koncina, E., Coowar, D., Heurtaux, T., et al. (2022) · Glia · doi:10.1002/glia.24149 · Cited by 65
Exercise as a therapeutic intervention for motor and non-motor symptoms in Parkinson’s disease: Evidence from rodent models
Crowley, E. K., Nolan, Y. M., & Sullivan, A. M. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.11.003 · Cited by 72
The Hidden Cell-to-Cell Trail of α-Synuclein Aggregates
Neupane, S., Cecco, E. D., & Aguzzi, A. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167930 · Cited by 69
α-Synuclein in Extracellular Vesicles: Functional Implications and Diagnostic Opportunities
Lööv, C., Scherzer, C. R., Hyman, B. T., Breakefield, X. O., & Ingelsson, M. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0317-0 · Cited by 68
Alpha-synuclein at the intracellular and the extracellular side: functional and dysfunctional implications
Ottolini, D., Calí, T., Szabó, I., & Brini, M. (2016) · Biological Chemistry · doi:10.1515/hsz-2016-0201 · Cited by 65
Neuroinflammation in neurodegeneration via microbial infections
Tran, V. T. A., Lee, L. P., & Cho, H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.907804 · Cited by 72
Immunochemical Detection of α-Synuclein Autoantibodies in Parkinson’s Disease: Correlation between Plasma and Cerebrospinal Fluid Levels
Horváth, I., Iashchishyn, I. A., Forsgren, L., & Morozova‐Roche, L. A. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00063 · Cited by 64
Gastrointestinal nervous system α-synuclein as a potential biomarker of Parkinson disease
Yan, F., Chen, Y., Li, M., Wang, Y.-Q., Zhang, W., Chen, X., & Ye, Q. (2018) · Medicine · doi:10.1097/md.0000000000011337 · Cited by 63
The Properties of α-Synuclein Secondary Nuclei Are Dominated by the Solution Conditions Rather than the Seed Fibril Strain
Peduzzo, A., Linse, S. S., & Buell, A. K. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00594 · Cited by 62
The Molecular Mechanisms of the Relationship between Insulin Resistance and Parkinson’s Disease Pathogenesis
Ruiz-Pozo, V. A., Tamayo-Trujillo, R., Cadena-Ullauri, S., Frias-Toral, E., Guevara-Ramírez, P., Paz-Cruz, E., Chapela, S., Montalván, M., Morales-López, T., Simancas-Racines, D., et al. (2023) · Nutrients · doi:10.3390/nu15163585 · Cited by 63
Gut microbiota, 1013 new pieces in the Parkinson's disease puzzle
Scheperjans, F. (2016) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000389 · Cited by 64
P. acnes-Driven Disease Pathology: Current Knowledge and Future Directions
Leheste, J. R., Ruvolo, K. E., Chrostowski, J. E., Rivera, K., Husko, C., Miceli, A., Selig, M. K., Brüggemann, H., & Torres, G. (2017) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2017.00081 · Cited by 64
The gut in Parkinson’s disease: Bottom‐up, top‐down, or neither?
Leclair‐Visonneau, L., Neunlist, M., Derkinderen, P., & Lebouvier, T. (2019) · Neurogastroenterology & Motility · doi:10.1111/nmo.13777 · Cited by 71
Are rodent models of Parkinson’s disease behaving as they should?
Vingill, S., Connor‐Robson, N., & Wade‐Martins, R. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.10.021 · Cited by 63
Gastrointestinal Immunity and Alpha-Synuclein
Barbut, D., Stolzenberg, E. D., & ZASLOFF, M. A. (2019) · Journal of Parkinson s Disease · doi:10.3233/jpd-191702 · Cited by 66
Overnutrition Induced Cognitive Impairment: Insulin Resistance, Gut-Brain Axis, and Neuroinflammation
Zhang, Q., Jin, K., Chen, B., Liu, R., Cheng, S., Zhang, Y., & Lü, J. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.884579 · Cited by 65
Microbiome Influence in the Pathogenesis of Prion and Alzheimer’s Diseases
D’Argenio, V., & Sarnataro, D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20194704 · Cited by 64
Gut-to-Brain α-Synuclein Transmission in Parkinson’s Disease: Evidence for Prion-like Mechanisms
Chen, M., & Mor, D. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087205 · Cited by 65
Gut mucosal cells transfer α-synuclein to the vagus nerve
Chandra, R., Sokratian, A., Chavez, K. R., King, S., Swain, S. M., Snyder, J. C., West, A. B., & Liddle, R. A. (2023) · JCI Insight · doi:10.1172/jci.insight.172192 · Cited by 65
Aggregated Alpha-Synuclein Transfer Efficiently between Cultured Human Neuron-Like Cells and Localize to Lysosomes
Domert, J., Sackmann, C., Severinsson, E., Agholme, L., Bergström, J. J. E., Ingelsson, M., & Hallbeck, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168700 · Cited by 59
The Impact of Chronic Intestinal Inflammation on Brain Disorders: the Microbiota-Gut-Brain Axis
Serra, D., Almeida, L. M., & Dinis, T. C. P. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1572-8 · Cited by 63
G ut F eelings Ab out α‐ S ynuclein in G astrointestinal B iopsies: B iomarker in the M aking?
Ruffmann, C., & Parkkinen, L. (2016) · Movement Disorders · doi:10.1002/mds.26480 · Cited by 60
Metagenomics of the Gut Microbiome in Parkinson's Disease: Prodromal Changes
Palacios, N., Wilkinson, J., Bjornevik, K., Schwarzschild, M. A., McIver, L., Ascherio, A., & Huttenhower, C. (2023) · Annals of Neurology · doi:10.1002/ana.26719 · Cited by 59
Lipids: Key Players That Modulate α-Synuclein Toxicity and Neurodegeneration in Parkinson’s Disease
Mori, A., Imai, Y., & Hattori, N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093301 · Cited by 60
Gut Microbial Metabolites in Parkinson’s Disease: Implications of Mitochondrial Dysfunction in the Pathogenesis and Treatment
Liang, Y., Cui, L., Gao, J., Zhu, M., Zhang, Y., & Zhang, H. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02375-0 · Cited by 59
A Proposed Roadmap for Parkinson’s Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-Synuclein
Merchant, K., Cedarbaum, J. M., Brundin, P., Dave, K. D., Eberling, J. L., Espay, A. J., Hutten, S. J., Javidnia, M., Luthman, J., Maetzler, W., et al. (2018) · Journal of Parkinson s Disease · doi:10.3233/jpd-181471 · Cited by 60
Locus coeruleus neurons are most sensitive to chronic neuroinflammation-induced neurodegeneration
Wang, Q., Oyarzabal, E. A., Song, S., Wilson, B. C., Santos, J. H., & Hong, J. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.01.003 · Cited by 59
Alpha-Synuclein to the Rescue: Immune Cell Recruitment by Alpha-Synuclein during Gastrointestinal Infection
Labrie, V., & Brundin, P. (2017) · Journal of Innate Immunity · doi:10.1159/000479653 · Cited by 60
New concepts in the pathogenesis and presentation of Parkinson’s disease
Sauerbier, A., Qamar, M. A., Rajah, T., & Chaudhuri, К. R. (2016) · Clinical Medicine · doi:10.7861/clinmedicine.16-4-365 · Cited by 59
Dysregulation of the Gut-Brain Axis, Dysbiosis and Influence of Numerous Factors on Gut Microbiota Associated Parkinson's Disease
Kaur, G., Behl, T., BUNGAU, S. G., Kumar, A., Uddin, M. S., Mehta, V., Zengin, G., Mathew, B., Shah, M. A., & Arora, S. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200606233050 · Cited by 57
Intermediates of α-synuclein aggregation: Implications in Parkinson's disease pathogenesis
Gadhe, L. G., Sakunthala, A., Mukherjee, S., Gahlot, N., Bera, R., Sawner, A. S., Kadu, P., & Maji, S. K. (2021) · Biophysical Chemistry · doi:10.1016/j.bpc.2021.106736 · Cited by 56
Pathogenic Mutations Differentially Regulate Cell-to-Cell Transmission of α-Synuclein
Guan, Y., Zhao, X., Liu, F., Yan, S., Wang, Y., Du, C., Cui, X., Li, R., & Zhang, C. X. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00159 · Cited by 54
Enteric Glia at the Crossroads between Intestinal Immune System and Epithelial Barrier: Implications for Parkinson Disease
Benvenuti, L., D’Antongiovanni, V., Pellegrini, C., Antonioli, L., Bernardini, N., Blandizzi, C., & Fornai, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239199 · Cited by 56
GI infections are associated with an increased risk of Parkinson’s disease
Nerius, M., Doblhammer, G., & Tamgüney, G. (2019) · Gut · doi:10.1136/gutjnl-2019-318822 · Cited by 60
Erythrocytic α-synuclein contained in microvesicles regulates astrocytic glutamate homeostasis: a new perspective on Parkinson’s disease pathogenesis
Sheng, L., Stewart, T., Yang, D., Thorland, E., Soltys, D., Aro, P., Khrisat, T., Xie, Z., Li, N., Liu, Z., et al. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00983-w · Cited by 56
Appendectomy may delay P arkinson's disease Onset
Mendes, A., Gonçalves, A., Vila‐Chã, N., Moreira, I. C., Fernandes, J., Damásio, J., Teixeira-Pinto, A. M., Taipa, R. J. F., Lima, A. B., & Cavaco, S. (2015) · Movement Disorders · doi:10.1002/mds.26311 · Cited by 60
Constipation and risk of Parkinson’s disease: A Danish population-based cohort study
Svensson, E., Henderson, V. W., Borghammer, P., Horváth–Puhó, E., & Sørensen, H. T. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.05.016 · Cited by 57
Gut, oral and nasal microbiota and Parkinson’s disease
Shen, L. (2020) · Microbial Cell Factories · doi:10.1186/s12934-020-01313-4 · Cited by 58
Role and Mechanism of Vitamin A Metabolism in the Pathophysiology of Parkinson’s Disease
Marie, A., Darricau, M., Touyarot, K., Parr‐Brownlie, L. C., & Bosch‐Bouju, C. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-212671 · Cited by 61
The Involvement of Neuroinflammation in the Onset and Progression of Parkinson’s Disease
Jurcău, A., Andronie-Cioară, F. L., Nistor-Cseppento, C. D., Pașcalău, N., Rus, M., Vasca, E., & Jurcău, M. C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914582 · Cited by 58
The Gut and Nonmotor Symptoms in Parkinson's Disease
Klingelhoefer, L., & Reichmann, H. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.05.027 · Cited by 53
Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update—I. Hypokinetic-rigid movement disorders
Jellinger, K. A. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02028-6 · Cited by 58
Brain regions susceptible to alpha-synuclein spreading
Guo, Y., Xiong, H., Chen, K., Zou, J.-J., & Lei, P. (2021) · Molecular Psychiatry · doi:10.1038/s41380-021-01296-7 · Cited by 51
An Efficient Procedure for Removal and Inactivation of Alpha-Synuclein Assemblies from Laboratory Materials
Bousset, L., Brundin, P., Böckmann, A., Meier, B., & Melki, R. (2016) · Journal of Parkinson’s Disease · doi:10.3233/jpd-150691 · Cited by 53
Self-citation
Oral, Nasal, and Gut Microbiota in Parkinson’s Disease
Li, Z., Lu, G., Luo, E., Wu, B., Li, Z., Guo, J., Xia, Z., Zheng, C., Su, Q., Zeng, Y., et al. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2021.10.011 · Cited by 52
Squalamine and trodusquemine: two natural products for neurodegenerative diseases, from physical chemistry to the clinic
Limbocker, R., Errico, S., Barbut, D., Knowles, T. P. J., Vendruscolo, M., Chiti, F., & ZASLOFF, M. A. (2021) · Natural Product Reports · doi:10.1039/d1np00042j · Cited by 54
RT-QuIC and Related Assays for Detecting and Quantifying Prion-like Pathological Seeds of α-Synuclein
Srivastava, A., Alam, P., & Caughey, B. W. (2022) · Biomolecules · doi:10.3390/biom12040576 · Cited by 50
Emerging therapeutic role of gut microbial extracellular vesicles in neurological disorders
Sun, B., Sawant, H., Borthakur, A., & Bihl, J. C. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1241418 · Cited by 52
Engineered bacterial extracellular vesicles for central nervous system diseases
Ji, N., Wang, F., Wang, M., Zhang, W. C., Liu, H., & Su, J. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.10.027 · Cited by 52
Microbes Tickling Your Tummy: the Importance of the Gut-Brain Axis in Parkinson’s Disease
Perez‐Pardo, P., Hartog, M., Garssen, J., & Kraneveld, A. D. (2017) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-017-0129-2 · Cited by 53
Detection of alpha‐synuclein conformational variants from gastro‐intestinal biopsy tissue as a potential biomarker for Parkinson's disease
Ruffmann, C., Bengoa‐Vergniory, N., Poggiolini, I., Ritchie, D. L., Hu, M. T., Alegre‐Abarrategui, J., & Parkkinen, L. (2018) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12486 · Cited by 55
Healthy Gut, Healthy Brain: The Gut Microbiome in Neurodegenerative Disorders
Chandra, S., Alam, M. T., Dey, J., Sasidharan, B. C. P., Ray, U., Srivastava, A. K., Gandhi, S., & Tripathi, P. P. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200413091101 · Cited by 50
Dysphagia: Thinking outside the box
Philpott, H., Garg, M., Tomic, D., Balasubramanian, S., & Sweis, R. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i38.6942 · Cited by 50
Cross-seeding of alpha-synuclein aggregation by amyloid fibrils of food proteins
Vaneyck, J., Segers‐Nolten, I. M. J., Broersen, K., & Claessens, M. M. A. E. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100358 · Cited by 50
Dopamine transporter availability reflects gastrointestinal dysautonomia in early Parkinson disease
Hinkle, J. T., Perepezko, K., Mills, K. A., Mari, Z., Butala, A., Dawson, T. M., Pantelyat, A., Rosenthal, L. S., & Pontone, G. M. (2018) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2018.08.010 · Cited by 49
Polystyrene Nanoplastics Hitch-Hike the Gut–Brain Axis to Exacerbate Parkinson’s Pathology
Liang, X., Huang, G., Wang, Y., Andrikopoulos, N., Tang, H., Ding, F., Li, Y., & Ke, P. C. (2025) · ACS Nano · doi:10.1021/acsnano.4c13914 · Cited by 53
Alpha-synuclein-based models of Parkinson's disease
Dehay, B., & Fernagut, P. (2016) · Revue Neurologique · doi:10.1016/j.neurol.2016.04.003 · Cited by 55
Interaction between Tea Polyphenols and Intestinal Microbiota in Host Metabolic Diseases from the Perspective of the Gut–Brain Axis
Yan, R., Ho, C., & Zhang, X. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202000187 · Cited by 49
Gut Microbiota Approach—A New Strategy to Treat Parkinson’s Disease
Liu, J., Xu, F., Nie, Z., & Shao, L. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.570658 · Cited by 52
Parkinson mice show functional and molecular changes in the gut long before motoric disease onset
Gries, M., Christmann, A., Schulte, S., Weyland, M., Rommel, S., Martin, M., Baller, M. K., Röth, R., Schmitteckert, S., Unger, M. M., et al. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00439-2 · Cited by 55
Single-Cell RNA Sequencing in Parkinson’s Disease
Ma, S., & Lim, S. B. (2021) · Biomedicines · doi:10.3390/biomedicines9040368 · Cited by 50
Inflammatory bowel disease induces pathological α‐synuclein aggregation in the human gut and brain
Espinosa‐Oliva, A. M., Ruiz, R., Soto, M. S., Boza‐Serrano, A., Rodriguez-Perez, A. I., Roca-Ceballos, M. A., García‐Revilla, J., Santiago, M., Serres, S., Economopoulus, V., et al. (2024) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12962 · Cited by 53
Neuropathology of Nonmotor Symptoms of Parkinson's Disease
Jellinger, K. A. (2017) · International review of neurobiology · doi:10.1016/bs.irn.2017.05.005 · Cited by 50

Authors: Holmqvist, S., Chutna, O., Bousset, L., Aldrin-Kirk, P., Li, W., Björklund, T., Wang, Z.-Y., Roybon, L., Melki, R., & Li, J.-Y.
Affiliations: Lund University (SE)
Centre National de la Recherche Scientifique (FR)
Northeastern University (CN)
ORCID: Holmqvist, Staffan
Bousset, Luc
Aldrin-Kirk, Patrick
Li, Wen
Björklund, Tomas
Wang, Zhan-You
Roybon, Laurent
Melki, Ronald
Venue: Acta Neuropathologica
Publisher: Springer Science and Business Media LLC
Published: 2014-10-09
Volume: 128
Issue: 6
Pages: 805-820
ISSN: 0001-6322 (ISSN-L)
1432-0533
DOI: 10.1007/s00401-014-1343-6
OpenAlex: W1995281235
Cited by: 925
References: 51
Citations by year: 2026: 47 · 2025: 67 · 2024: 73 · 2023: 67 · 2022: 110 · 2021: 132 · 2020: 102 · 2019: 107 · 2018: 75 · 2017: 59 · 2016: 43 · 2015: 38 · 2014: 3
FWCI: 30.94
Type: journal article
Language: en
Open access: green
lup.lub.lu.se
Licence: other-oa
www.springer.com/tdm (tdm)
Locations: Acta Neuropathologica (publishedVersion)
PubMed (publishedVersion)
HAL (submittedVersion)
Lund University Publications (Lund University) (submittedVersion, other-oa)
Funders: Agence Nationale de la Recherche (ANR-11-BSV8-0021)
Topics: Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
Keywords: Parkinson's disease, alpha-synuclein, Lewy bodies, gut-brain axis, vagus nerve, retrograde transport, enteric nervous system, dorsal motor nucleus of the vagus, axonal transport, alpha-synuclein aggregation, rat model
MeSH terms: Animals, Axonal Transport, Brain, Disease Models, Animal, Humans, Parkinson Disease, Recombinant Proteins, Vagus Nerve, Rats, Sprague-Dawley, Disease Progression, Gastrointestinal Tract, Cell Line, Tumor, alpha-Synuclein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks